Trials / Unknown
UnknownNCT01385670
InterSEPT: In-Tunnel SeptRx European PFO Trial
InterSEPT: In-Tunnel SeptRx European PFO Trial: A Prospective, Multi-Center Study to Evaluate the Safety and Performance of the SeptRx IPO PFO Closure System
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- SeptRx, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the safety, performance, and effectiveness of the SeptRx IPO PFO Closure System in the treatment of Patent Foramen Ovale (PFO) in patients who are amenable to percutaneous closure of their PFO defects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcatheter PFO closure with the SeptRx Intrapocket PFO Occluder (IPO) | Transcatheter PFO closure |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-06-01
- First posted
- 2011-06-30
- Last updated
- 2011-06-30
Locations
2 sites across 2 countries: France, Germany
Source: ClinicalTrials.gov record NCT01385670. Inclusion in this directory is not an endorsement.